Nephrology Times
Latest News
The cost per response of terlipressin plus albumin was lower than M&O+albumin and norepi+albumin.
Assessing the early impact of risk categorization on management of patients with DKD.
Protocol for trial of daprodustat for treatment for anemia in pediatric patients with CKD stage ≥3.
Examining efficacy and safety of sacubitril/valsartan for patients with CKD.
A >30% reduction in serum creatinine inpatients with hepatorenal syndrome treated with terlipressin.
Gaps in care in treating proteinuria in patients with DKD.
Case study of a patient with CKD-associated anemia caused by a failed allograft.
Risk for hyperkalemia with finerenone treatment.
Advertisement
Conferences
The National Kidney Foundation's premier educational event covering advancements in all subspecialties of nephrology
The joint annual meeting of the American Society of Transplantation and the American Society of Transplant Surgeons
The American Society of Nephrology's annual meeting to highlight the latest scientific and medical advances in the field
The annual meeting hosted by the American Nephrology Nurses Association featuring clinical practice updates
Advertisement
Highlights From NKF Spring Clinical Meetings 2023
Up to 38% of patients with end-stage renal disease experience cognitive impairment. The risk for developing ...
According to the United States Renal Data System, use of home dialysis has increased since 2017. Across all payer types, ...
While COVID-19 is recognized as a typical syndrome of acute respiratory illness, it can also affect multiple organ ...
Monogenic kidney diseases are associated with approximately 10% of occurrences of chronic kidney disease (CKD). ...
